BY K A R E N WR I G H T -WHAT I WANT TO TALK TO YOU ABOUT today are trends in cancer in industrial coun tries."

Cliffo rd a . jo n e s HERBERT M, JO NES MELVIN O, CLO SE JO S E P H W.

J .

V& Z o ff 1226 THE NEW ENGLAND JOURNAL OF MEDICINE May 8, 1986 Vol SPECIAL ARTICLES Tat PROGRESS AGAINST CANCER?

PRESS QUERY COMPANY (OpUnit or Corporate): CORPORATE X News Bureau SUBJECT: Sturgeon Trial X J.

Deposition Summary: W.

Roman - N3B Monsanto 1^ 1- M ONSANTO INDUSTRIAL CHEM ICALS CO BOO N Lindbergh Boulevard Si, L o u i s .

S t/> m -S I -- 8" g s M*P' SSEH/ESC___________ (to.

The University ofDayton October 3, 1985 Dr.

I Monsanto MON3ANTO INDUSTRIAL CHEMICALS CO. 800 N.

Monsanto FROM < NAME-LOCATION --PHONE) J.

FILE NAME: Abex (ABX) DATE: 1980 May 13 DOC#: ABX233 DOCUMENT DESCRIPTION: Abex Memo RE O.E.

FILE NAME: Allied Signal Bendix (ASB) DATE: 1980 DOC#: ASB136 DOCUMENT DESCRIPTION: Abstract from Scientific Journal - Asbestos i >nl, la58 s _ v ippiement -<nee and I:iinIbook M.

heute Ocular Irritation Test vith 1-3493 .

AR286 -- 0733 `SUMMARY FOR WORK PERFORMED BY THE GERMAN ARMY ON FOAM EXTINGUISHING AGENTS MANUFACTURED BY MULTIPLE COMPANIES EST SUBSTANCE Identity: A mixture containing perfluorooctanesulfonate, which may also be referred to as PFOS, FC-95,oras a compoon fFeC-n 20t 3. (1-Octanesulfonic acid) (CAS # 2795-39-3).